Related Experiment Videos
No SMAD4 hypermethylation in colorectal cancer
1Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland.
Abstract:
The chromosome region 18q21 is frequently deleted in colorectal cancers. Three candidate tumour suppressor genes, DCC, SMAD4 and SMAD2, map to this region. The SMAD4(DPC4) gene was recently identified as a candidate pancreatic cancer suppressor gene. It is also a gene for juvenile polyposis tumour predisposition syndrome. Somatic SMAD4 mutations have been detected in some colorectal carcinomas. However, the frequency of these mutations is relatively low, and whether SMAD4 plays a key role in colorectal tumorigenesis is still unclear. In addition to loss of chromosomal material and intragenic mutations there is a third mechanism, DNA methylation, which may have an important role in gene inactivation. In the present study, we examined whether promoter hypermethylation could be a mechanism for SMAD4 inactivation. In total, 42 colorectal tumours were selected for the methylation analysis and no evidence of promoter hypermethylation was found. Our result suggests that hypermethylation of the SMAD4 promoter region is not a frequent event in colorectal tumorigenesis.
Insights
Promoter hypermethylation does not frequently inactivate the SMAD4 gene in colorectal tumors. This study found no evidence of SMAD4 promoter hypermethylation in 42 colorectal tumor samples, suggesting other mechanisms are involved in colorectal cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The 18q21 chromosome region is frequently deleted in colorectal cancers.
- SMAD4 (DPC4) is a candidate tumor suppressor gene implicated in pancreatic cancer and juvenile polyposis.
- Somatic SMAD4 mutations are infrequent in colorectal carcinomas, leaving its role unclear.
Purpose of the Study:
- To investigate promoter hypermethylation as a mechanism for SMAD4 gene inactivation in colorectal tumorigenesis.
- To determine the frequency of SMAD4 promoter hypermethylation in colorectal tumors.
Main Methods:
- Analysis of DNA methylation in the promoter region of the SMAD4 gene.
- Selection of 42 colorectal tumor samples for methylation analysis.
Main Results:
- No evidence of SMAD4 promoter hypermethylation was detected in the analyzed colorectal tumors.
- The study did not find promoter hypermethylation to be a common mechanism for SMAD4 inactivation.
Conclusions:
- Promoter hypermethylation is not a frequent event contributing to SMAD4 inactivation in colorectal tumorigenesis.
- Alternative mechanisms likely account for SMAD4 gene silencing in colorectal cancer development.